Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 19;23(8):286.
doi: 10.1208/s12249-022-02434-2.

Particle Property Characterization and Data Curation for Effective Powder Property Modeling in the Pharmaceutical Industry

Robert C Wadams  1 , Ilgaz Akseli  2 , Jacob Albrecht  3   4 , Ana P Ferreira  5 , John F Gamble  5 , Michael Leane  5 , Stephen Thomas  2 , Yue Schuman  3 , Lauren Taylor  3 , Mike Tobyn  5
Affiliations
Review

Particle Property Characterization and Data Curation for Effective Powder Property Modeling in the Pharmaceutical Industry

Robert C Wadams et al. AAPS PharmSciTech. .

Abstract

Computational modeling, machine learning, and statistical data analysis are increasingly utilized to mitigate chemistry, manufacturing, and control failures related to particle properties in solid dosage form manufacture. Advances in particle characterization techniques and computational approaches provide unprecedented opportunities to explore relationships between particle morphology and drug product manufacturability. Achieving this, however, has numerous challenges such as producing and appropriately curating robust particle size and shape data. Addressing these challenges requires a harmonized strategy from material sampling practices, characterization technique selection, and data curation to provide data sets which are informative on material properties. Herein, common sources of error in particle characterization and data compression are reviewed, and a proposal for providing robust particle morphology (size and shape) data to support modeling efforts, approaches for data curation, and the outlook for modeling particle properties are discussed.

Keywords: characterization; computational modeling; particle properties.

PubMed Disclaimer

References

    1. Sacks LV, Shamsuddin HH, Yasinskaya YI, Bouri K, Lanthier ML, et al. Scientific and Regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000–2012. JAMA. 2014;311(4):378–84. - DOI - PubMed
    1. Chattoraj S, Daugherity P, McDermott T, Olsofsky A, Roth W, Tobyn M. Sticking and picking in pharmaceutical tablet compression: an IQ consortium review. J Pharm Sci. 2018;107(9):2267–82. - DOI - PubMed
    1. Leane M, Pitt K, Reynolds G. Mfg classification syst MCSW. A proposal for a drug product manufacturing classification system (MCS) for oral solid dosage forms. Pharm Dev Technol. 2015;20(1):12–21. - DOI - PubMed
    1. Leane M, Pitt K, Reynolds GK, Dawson N, Ziegler I, Szepes A, et al. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing. Pharm Dev Technol. 2018;10:964–77. - DOI
    1. Mamidi HK, Mishra SM, Rohera BD. Application of modified SeDeM expert diagram system for selection of direct compression excipient for liquisolid formulation of Neusilin US2. Journal of Drug Delivery Science and Technology. 2021;64:1–11. - DOI

LinkOut - more resources